Introduction
Infective endocarditis (IE) is one of the most lethal infectious diseases in the western world with mortality rates ranging from 20 to 75%. 1 -4 This underlines the importance of prevention of this devastating disease. The role of prophylaxis, however, is controversial, and there is much debate on the strictness of its use in patients at risk. In 2007, the American College of Cardiology/American Heart Association (ACC/AHA) introduced the revised guideline on the treatment of IE. 5 This was followed in 2008 by the National Institute of Clinical Excellence (NICE) guidelines. 6, 7 The European Society of Cardiology (ESC) followed in 2009 and in 2015 with the new guidelines on prevention, diagnosis, and treatment of IE. 8, 9 A result of all three revised guidelines was a much less strict policy regarding the use of prophylaxis in patients at risk of developing IE. Before these revisions, virtually all patients with valvular anomalies received antibacterial prophylaxis, whereas after the revision, this was only indicated in patients with previous IE, prosthetic heart valves, and cyanotic congenital heart disease. The 2007 ACC/AHA and the 2009 ESC guidelines use virtually the same criteria in determining the indications for prophylaxis. 5, 8 Recently, the ESC published a new endocarditis guideline in which the indications for prophylaxis remained unchanged. 9 In early 2015, Dayer et al. demonstrated that since the introduction of the NICE guideline there has been a drop in the use of prophylaxis and at the same time there has been a rise in the incidence of IE. 10 Later that year, Pant et al. showed a similar trend for the Streptococcus-related IE incidence in the USA. 11 In Europe, there is scant evidence on the IE incidence after the introduction of the revised and updated IE guidelines. 12 With an ageing population and an increase in the use of invasive medical techniques, there is an increase in IE in the developed world. 3,10 -16 As the use of prophylaxis is greatly reduced, we hypothesize that the increase of IE will project above the historical trend after the introduction of the 2009 ESC guideline. Furthermore, a more detailed analysis of individual patients from three general hospitals gives insight into a population that is not biased by referral to a tertiary centre, which will treat patients mainly by surgical intervention.
Materials and methods
We performed a nationwide retrospective secular trend study analysed as an interrupted time series to investigate the incidence of IE in the Netherlands. Data collection took place between 2012 and 2014, and the median follow-up was 4.2 years (range 0.3 -8.0 years). Patients were identified using the insurance database between 2005 and 2011. Data were extracted by the Dutch Healthcare Authority (Nederlandse Zorg Autoriteit). Individual patients were anonymized but represent unique individual patients. This was done in order to exclude the possibility of duplicate entry of patients as two different hospitals could claim revenues for treating the same patient (e.g. one hospital diagnosed and one hospital operated and treated the patient afterwards). This insurance database has a code uniquely for IE. The Dutch insurance system changed its registration after 2011 and therefore patients after this period could not be included in this analysis. Annual incidence was corrected for the annual population growth according to the National Bureau of Statistics (Centraal Bureau voor de Statistiek).
At the same time, IE patients in three general hospitals in the Netherlands [Spaarne (former Kennemer) Gasthuis Haarlem, Gelre Hospital Apeldoorn, Gelre Hospital Zutphen] were used as a sample. These patients were identified using the in-hospital registration of the insurance data that was used to identify patients nationwide. All patient records were reviewed in order to determine patient characteristics such as age, gender, previous medical history, affected valves, organisms, microorganism access location, mortality, and morbidity. Patients with possible IE but treated as definite IE according to the modified Duke criteria were included (e.g. surgical intervention or 6 weeks antibiotic treatment). A few patients in our sample population (5.1%) had disease onset in 2004 but ended their hospitalization in 2005 and were therefore coded according to insurance database. These patients were included in this research in order to achieve the largest possible sample size. In order to minimize potential selection bias that would affect a representative sample of the general population in the Netherlands, the choice was made to select general hospitals only instead of tertiary centres where patients are being referred to for surgical intervention.
As this is a retrospective study, according to Dutch law (Wet Medisch-Wetenschappelijk Onderzoek met Mensen), an evaluation by a local medical ethics committee was not necessary.
Mortality was defined as all-cause mortality within the follow-up period. Adverse events were defined as IE-related adverse events during hospitalization requiring medical intervention or prolonging hospital stay. The adverse events included were thromboembolic events (including stroke and peripheral septic emboli), bleeding, recurrent endocarditis, tachyarrhythmias, and abscess formation at any location.
Statistical analysis was performed using SPSS (IBM, Armonk, NY, USA) and R (www.rproject.org). Student's t-test was used for continuous variables and Fisher's exact test/x 2 test for categorical variables.
Multivariate logistic regression analyses were performed to determine independent risk factors for mortality and morbidity. Multivariate analysis included affected valves, microorganism, age, and sex. Furthermore, on the nationwide date, a secular trend study analysed as an interrupted time series was performed. Rate ratios (RR) were used to determine significant changes in male-to-female ratios and the incidence after the introduction of the 2009 ESC guideline. A two-tailed P-value of ,0.05 was considered statistically significant.
Results

The incidence of infective endocarditis after the 2009 European Society of Cardiology guideline introduction
Between 2005 and 2011, a total of 5213 patients were hospitalized with IE in the Netherlands. During this period, there was a significant increase in IE from 30.2 new cases per 1 000 000 in 2005 to 62.9 cases per 1 000 000 in 2011 (P , 0.001). Historically, more male subjects are affected with IE; 69.9% of the patients in our population were men. The increase in IE was similar in both sexes. The male-to-female ratio remained consistent during the study period and was similar in the overall cohort as well as in our sample as mentioned earlier (see Figure 1 ). In 2009, the incidence of IE increased significantly above the projected historical trend (RR: 1.327, 95% CI: 1.205-1.462; P , 0.001) (see Figure 2 ). This coincides with the introduction of the 2009 ESC guideline. The rise in incidence was mainly driven by the increase in IE incidence in men in which the significant increase in incidence falls in the same year as the introduction of the ESC guidelines (RR: 1.360, 95% CI: 1.211-1.529; P , 0.001) (see Figure 3 ). In the female cohort, a similar significant trend was observed 1 year (2008) before Figure 1 Male-to-female rate ratios for the national cohort.
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the introduction of the ESC guideline (RR: 1.254, 95% CI: 1.053 -1.496; P ¼ 0.005) (see Figure 4 ).
Patient characteristics of the sample population
Three hospitals were chosen to analyse in detail as a representative sample of the general population. Between 2005 and 2011, we identified 216 individual cases of IE. On the basis of the three general hospitals and the per-hospital catchment area, this would amount to an annual incidence of IE of 5.7 new cases per 100 000 persons per year. This incidence is similar to the nationwide incidence. The mean age at the time of the diagnosis was 67.5 years (22 -97). Men were more often affected than women, 62.5 vs. 37.5% in our sample population, which was not statistically significantly different from the nationwide cohort (P ¼ 0.45). Definite IE according to the modified Duke criteria was diagnosed in 82.8% of the patients. Transthoracic echocardiogram confirmed the diagnosis in 19.4% of the cases and Transoesophageal echocardiogram in 74.1%. In 6.5% of the patients, no vegetation was visible. A total of 40.7% of the patients had a pre-existing valvular condition predisposing for IE.
Introduction of the 2009 European Society of Cardiology guideline
Comparing the population before and after the introduction of the new guideline, there was no difference in mortality (OR ¼ 1.82, 95% CI: 0.97 -3.50; P ¼ 0.0665) or the number of adverse events (OR ¼ 0.60, 95% CI: 0.34-1.04; P ¼ 0.0698). There was no significant difference in the chance of receiving a surgical intervention before and after the introduction of the ESC guideline. However, there was a significant difference in the mean age of the surviving patients before and after the guideline (see Table 1 ). Furthermore, the streptococci-related IE increased after the introduction of the 2009 guideline from 31.1 to 53.2% (P ¼ 0.0031) (see Table 1 ). Of the whole cohort, only 1/216 (0.46%) patient had received prophylaxis.
Affected valves
One-third of the patients had prosthetic valve IE (30.1%), all of which were left sided. A pacemaker device lead located at the right side of the heart was affected in 7.9% of the cases. In 0.9%, there was a combined infection of a left-sided heart valve and a pacemaker device lead. Only 4.6% patients had isolated tricuspid or pulmonary Increased incidence of infective endocarditis after the 2009 ESC guideline update valve IE, none of which were related to a pacemaker device lead infection. One patient had an infected myxoma.
Microbiology
Positive blood cultures were present in 90.7% of the patients. In 36.1% of our population, Staphylococcus was the pathogen. A total of 30.1% of all patients had Staphylococcus aureus (SA) cultured, making it the single most prevalent microorganism. Of the entire population, only 0.5% of the positive cultures were methicillin-resistant SA (MRSA). The total amount of various streptococci was 37.4%. Streptococcus mitis was the single most prevalent Streptococcus at 8.3%; Streptococcus bovis (gallolyticus) ranked second at 6.0%. A bacterial access location was found in 53.2% of the patients. The most prevalent access locations were oropharynx (13.8%), skin (10.6%), urinary tract (5.6%), and the colon (4.6%).
Outcomes Mortality
All-cause mortality was 36.1%. The mortality in women was significantly higher than that in men (49.3 vs. 28.2%, P ¼ 0.002). Female sex was an independent prognostic factor for mortality (OR ¼ 2.35, 95% CI: 1.29 -4.28; P ¼ 0.005). The mean age at the time of death was 76, whereas the mean age for the surviving patients was statically significantly lower at 65 (P , 0.001; 95% CI: 4.66 -12.15). Age was also an independent prognostic factor for mortality (per life year OR ¼ 1.05, 95% CI: 1.03 -1.08; P , 0.001) (see Table 2 ). Age and gender were not independent prognostic factors for adverse events.
Mortality was higher in prosthetic valve IE (42/65, 66.2%) when compared with native valve IE (56/151, 37.0%) (P , 0.001). In a multivariate analysis between prosthetic valve IE and native valve IE, there was no significant difference in mortality.
Surgical vs. conservative treatment
A total of 38.9% of patients were accepted for surgical intervention. Mortality was higher in the conservative treatment group (46.9%) when compared with the surgical group (19.0%) (P ≤ 0.001). In a multivariate analysis, this difference remained significant (OR ¼ 3.39, 95% CI: 1.80-6.38; P , 0.001) (see Table 2 ). SA endocarditis or prosthetic valve IE were not independent prognostic factors for receiving surgical intervention. Women were less likely to have surgical intervention performed (OR ¼ 1.96, 95% CI: 1.06-3.61; P ¼ 0.031). Also, ageing was an independent prognostic factor for not receiving surgery in a multivariate analysis (annual OR ¼ 1.04, 95% CI: 1.02-1.06; P , 0.001) (see Table 3 ).
The incidence of adverse events was higher in the surgical group (73.8%) than that in the conservative treatment group (48.4%). Surgical intervention was an independent prognostic factor for adverse events (OR ¼ 3.03, 95% CI: 1.64-5.55; P , 0.001).
Discussion
To our knowledge, this is the first nationwide research that demonstrates a significant increase in the incidence of IE above the historical trend after the introduction of the ESC 2009 guidelines. 8 Although there has been some research on the incidence after the introduction of the revised ESC guidelines, mainly in France, this is the first research that focuses on a country as a whole and spans a longer period of time. 12 Although previous research from
Pant et al. already demonstrated a significant rise in Streptococcus IE incidence, this focused on the ACC/AHA IE guidelines. The fact that the same trend is seen after the 2009 ESC guidelines is a confirmation of Pant et al.'s results as both the ACC/AHA and ESC use virtually similar criteria for prophylaxis. 5, 8, 11 As Drayer et al. demonstrated a similar trend in the UK, the evidence seems to be tipping the scale in favour of a more strict attitude towards prophylaxis in patients at risk that are currently not covered by the IE guideline. 10 However, care must be taken when interpreting these results. These are trends and not prospective studies. Furthermore, possible harm done by the abundant use of antibiotics in prophylaxis must be considered when trying to prevent a relatively uncommon disease (e.g. anaphylaxis, antibiotic resistance). When looking at the temporal relationship between the publication of the ESC guideline in August 2009 and the penetration of this guideline within the healthcare profession, it is important to consider the fact that the National Heart Foundation (Nederlandse Hart Stichting) published a wide spread folder in December 2008 containing the revised criteria for prophylaxis as well as communicated by its author in the Nederlands Tijdschrift voor Geneeskunde. 17 Therefore, at the time of official publication of the new endocarditis guideline, this was already in wide use in the Netherlands. 17 The significant difference in mean age at the time of death before and after the ESC guideline introduction could be due to increasing cohort of elderly patients at risk for IE. The cohort of the so called baby boom generation is ageing and coming in the range of patients prone for IE.
Our study also showed that SA is the single most frequent organism. This is probably explained by the fact that the population prone for IE is increasing. An ageing population with an increase in degenerative heart valve disease, the increased use of prosthetic heart valves, and the increased incidence of pacemaker devices combined with a better prognosis in patients with congenital heart disease makes for a much larger cohort at risk. 16 At the same time, there is a rise in invasive procedures in just this population which is a risk factor for IE. As ,1% of our population had MRSA cultured, this indicates that a strict use of antibiotics combined with greater awareness among healthcare workers may prevent the spread of MRSA in the IE population. Before and after the 2009 ESC guideline, we see a significant increase in the number of streptococci-related IE cases. This could reflect the less strict indication for prophylaxis as this mainly targets streptococci. The fact that in the patients with an identified microorganism entry site the most prevalent entry site was the oropharyngic cavity is a worrying finding as this is the main target for antibiotic prophylaxis. This is emphasized as one considers that the most prevalent Streptococcus is S. mitis. Furthermore, the other main entry sites were the gastrointestinal and urinary tracts and the skin. The former two are affected by the prophylaxis guideline as well.
In a few number of cases, no organism was cultured. This may be due to a general practitioner staring antibiotics prior to presentation in one of the sample hospitals.
The mortality due to IE is considerable in our population and higher than that in various other research. 1 -4,13 As most research focuses on tertiary centres that have a great selection bias, this may explain the higher mortality rate in our population. Patients no longer eligible for surgical intervention may enter a palliative setting and therefore may not be included in studies on IE that most of the time run in larger surgical clinics. This may indicate that the advances in survival we have made in recent history may be influenced by selection bias. To our knowledge, this is one of the few studies that focuses on the general population instead of selecting patients suitable for surgical intervention as is being done in most studies. 1, 2, 4, 13 The mortality in women is significantly higher than that in men, and they receive less surgical intervention, which in itself is a prognostic factor for survival. The mechanism behind this is poorly understood but is confirmed by various other studies.
The difference in moment of increase in incidence between the male and female population may be explained by the fact that IE is more often underdiagnosed and treated less aggressive in women than in men, a fact that could explain the higher female mortality rate as well. Another explanation might be that men, as they are obviously more prone to endocarditis, may be more susceptible for IE when prophylaxis guidelines are less strict. We hypothesize that poorer oral hygiene in men combined with less strict prophylaxis has led to the significant increase in just this population.
One-third of IE patients have prosthetic valve IE. This reflects the growing incidence in the use of prosthetic material in cardiac surgery and will only increase in the future. The low incidence in right-sided IE is caused by the dwindling number of intravenous drug users in the Netherlands. 18 This group of patients, historically at risk for IE, is getting smaller over the course of time and may disappear altogether in the future. The mortality in the conservatively treated group of patients is much higher than that in the surgical group. This reflects a selection bias; those fit for surgery will have a better pre-operative condition than those unfit for surgical intervention. A larger number of patients will be treated in a palliative setting as they are no longer eligible for surgical intervention. As there was no selection bias in our study, this may explain the high mortality rate in the entire population and even more so in the cohort that recieved a conservative treatment.
Limitations
There are several limitations to this study. This is a retrospective observational study, and although we have demonstrated a temporal relation, causality cannot be proven. However, almost all observational studies with the same study design show the same results. 10, 11 Furthermore, there was no correction for population composition. An ageing population is at higher risk for the development of IE. A correction for immigration of people from countries with a higher risk of rheumatic heart valve disease was also not performed and could influence the results as well.
Another limitation is the possible small sample size. However, in contrast to other studies on the subject, we have detailed and verified information on our sample patients and do not depend on discharge information that is subject to registration of discharge diagnosis and greatly depends on the physicians' will to register diagnosis properly. We therefore feel that our sample population is representative for the nationwide cohort.
Finally, we have no information on the prescription of antibiotics before and after the 2009 guideline introduction. However, the National Heart Foundation (Nederlandse Hart Stichting) has been quite thorough in its education of healthcare professionals responsible for the prophylaxis in patients at risk, and we expect quite rigorous adherence to these guidelines.
Conclusion
The incidence of IE in the Netherlands is increasing, and since the introduction of the 2009 ESC guideline, the increase of IE projected above the historical trend. IE is a dangerous disease with high mortality rates in women and the elderly, which has hardly changed over the years. SA remains the single most common pathogen, whereas streptococci as a group remain the most common pathogen. After the 2009 ESC guideline, we see an increase in the number of streptococci-related cases of IE. Caution is advised in interpreting these results as this is an observational study and prospective data are lacking. In order to settle the debate on the relationship between prophylaxis and IE incidence, prospective studies should be performed in patients at risk.
